Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > Trading pattern and thoughts
View:
Post by DigitalSpurs on Apr 07, 2020 1:36pm

Trading pattern and thoughts

What's funny here is that the few are looking to sell and it's the same markers for the sellers for the past two weeks who are trying to flip the small profits, but end up selling back to themselves.

This will fly soon! I have a feeling more news is around the corner! No way the financing was just sitting around waiting on nothing - time is precious and governments need treatments right away.

Looks like a new base at 14c - should end at 15c today!
Comment by theNorm on Apr 07, 2020 1:50pm
8.8 million shares traded so far today makes us the most active Venture stock.  With patients being selected for clinical trials and the just announced dream financing, by the backers of Aurora, it should make for a most interesting close today, IMO
Comment by Torontonine on Apr 07, 2020 2:55pm
From my understanding clinical trials are going to be setup in different parts of the world now that they have the funding. Should be an interesting play when this new is confirmed.
Comment by laroplex on Apr 07, 2020 3:11pm
Hey Torontonine i agree with you 100%....You are bang-on.....Covid-19 is a world pandemic.....Why would Guy our chief in command would want more than the $1 million.... originally called for that amount...Todays news is HUGE,,,,,we have option to our discretion in pulling out increments of the $6 million needed, if needed....I am sure Guy will be extremenly prudent on the drawdown....Alumima is ...more  
Comment by MaterialWorld on Apr 07, 2020 3:28pm
Fantastic posts Torontonine and laroplex. Your right, Guy has definately got something up his sleeve. From 1 Million to 6 Million. Something's up.     MW
Comment by Accept2 on Apr 07, 2020 3:12pm
Also remember they have an airstrip behnd the facility where huge planes could take off and land to deliver goods to other countries, such as China. Its not like they only have to sell in one area or nation. As long as they can export, things s/b pretty good.At least thats how I see it........
Comment by theNorm on Apr 07, 2020 4:11pm
ICO went nuts in the last hour and a half of trading.  I wonder how many boards like ours it got mentioned on?  No real news other than speculation they will get 6 million dollar payment if one of their drugs they licensed goes into phase III trials in this covid 19 crisis.  See what happens overnight I guess.  GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities